article thumbnail

The future of cancer immunotherapy: exclusive webinar

Drug Discovery World

Veronique Baron from BPS Bioscience discusses the tools required to research and develop new oncology therapies, such as proteins, antibodies, cell lines, assay kits and viral tools. Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ Register now.

article thumbnail

Learn about cancer immunotherapy in this webinar

Drug Discovery World

Veronique Baron from BPS Bioscience discusses the tools required to research and develop new oncology therapies, such as proteins, antibodies, cell lines, assay kits and viral tools. Hosted by DDW and supported by BPS BioScience and AcroBiosystems, ‘Cancer immunotherapy – where will the future opportunities be?’ Register now.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Alternatively, some targets require novel, innovative solutions that may not be accessible in conventional drug discovery labs. Opportunities, options, and outsourcing.

article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

Assays are tests designed to assess various properties (like potency) of chemical or biological samples. In addition to assessing binding capabilities, assays can also be used to characterize the activity elicited by a product, whether bound or unbound to the target of interest. Code in order to have their products approved by the FDA.